Medfirst Healthcare ServicesROCO:4175 +0.19%71 ROE % is 13.65% as of Dec. 2025, which is 20% above its 10-year median of 11.35. GuruFocus rates ROCO:4175 with a GF Score™ of 71/100 and a GF Value™ of NT$74.49 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 626 Healthcare Providers & Services companies, Medfirst Healthcare Services ranks better than 63.9% on this metric.
The historical rank and industry rank for Medfirst Healthcare Services's ROE % or its related term are showing as below:
ROCO:4175'
s ROE % Range Over the Past 10 Years
Min: 3.33 Med: 11.35 Max: 15.46
Current: 10.41
During the past 13 years, Medfirst Healthcare Services's highest ROE % was 15.46%. The lowest was 3.33%. And the median was 11.35%.
ROCO:4175's ROE % is ranked better than 63.9% of 626
companies
in the Healthcare Providers & Services industry
Industry Median: 5.805
vs ROCO:4175: 10.41
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Dec. 2025) net income data. The Revenue data used here is four times the quarterly (Dec. 2025) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
Medfirst Healthcare Services ROE % Related Terms
Medfirst Healthcare Services ROE % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Medfirst Healthcare Services's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medfirst Healthcare Services ROE % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Medfirst Healthcare Services's ROE % distribution charts can be found below:
* The bar in red indicates where Medfirst Healthcare Services's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Dec. 2025) net income data.
ROE % is displayed in the 30-year financial page.
Medfirst Healthcare Services (ROCO:4175) has a ROE % of 13.65% as of Dec. 2025. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Medfirst Healthcare Services and its competitors. This is 20% above median its historical median of 11.35. Over the past decade, Medfirst Healthcare Services' ROE % has ranged from 3.33 to 15.46. According to the industry distribution chart, Medfirst Healthcare Services ranks #226 out of 626 companies in the Healthcare Providers & Services industry, placing it in the top 36.1%.
Is Medfirst Healthcare Services' ROE % too high?
Medfirst Healthcare Services' current ROE % of 13.65% is 20% above median its 10-year median of 11.35. Over the past 10 years, this metric has ranged from a low of 3.33 to a high of 15.46. The Healthcare Providers & Services industry median ROE % is 5.81. Medfirst Healthcare Services' value of 13.65% is 135.1% above this industry median. Based on the distribution chart, Medfirst Healthcare Services ranks #226 out of 626 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Medfirst Healthcare Services has a GF Score™ of 71/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medfirst Healthcare Services' ROE % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Medfirst Healthcare Services ranks #226 out of 626 companies for ROE %. This puts Medfirst Healthcare Services in the upper half of its industry. The industry median ROE % is 5.81. Medfirst Healthcare Services' value of 13.65% is 135.1% above this benchmark. Historically, Medfirst Healthcare Services' own ROE % has ranged from 3.33 to 15.46 over the past decade. While the company's 10-year median is 11.35 vs. the industry median of 5.81, Medfirst Healthcare Services has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 5.81, based on 626 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medfirst Healthcare Services's current ROE % of 13.65% is 135.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Medfirst Healthcare Services and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 5.81 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medfirst Healthcare Services's current ROE % is 13.65%, which is 20% above median its own 10-year median of 11.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medfirst Healthcare Services stock overvalued right now?
Based on GuruFocus' analysis, Medfirst Healthcare Services (ROCO:4175) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$74.49, compared to a current price of NT$53.20 — trading 28.6% below its estimated fair value. The current ROE % is 13.65%, which is 20% above median its 10-year median of 11.35 and 135.1% above the Healthcare Providers & Services industry median of 5.81. Medfirst Healthcare Services' overall GF Score™ is 71/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Medfirst Healthcare Services (ROCO:4175), the current ROE % is 13.65% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medfirst Healthcare Services (ROCO:4175) Overvalued in 2026?
Based on GuruFocus' analysis, Medfirst Healthcare Services stock appears to be undervalued.
The current stock price of NT$53.20 is trading 28.6% below its estimated GF Value™ of NT$74.49.
GuruFocus considers Medfirst Healthcare Services to be Modestly Undervalued.
Key valuation signals for ROCO:4175:
ROE %: 13.65% (20% above median its 10-year median of 11.35)
GF Value™: NT$74.49 vs. price of NT$53.20 (28.6% below fair value)
Industry Position: 135.1% above the Healthcare Providers & Services median (#226 of 626)
No single metric tells the full story. See the ROCO:4175 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medfirst Healthcare Services Inc is mainly engaged in the sale of medical supplies and the management of shopping malls. The company's geographical segment includes Mainland China and Taiwan. It generates maximum revenue from Taiwan. The company derives a majority of its revenue from medical care products followed by health care.
71GF Score
Get the complete analysis for ROCO:4175
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4175 has been successfully added to your 
